Trials / Unknown
UnknownNCT06416956
Baby-CINO: CaffeINe Treatment Optimisation in Premature Infants
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- University of Oxford · Academic / Other
- Sex
- All
- Age
- 37 Weeks
- Healthy volunteers
- Not accepted
Summary
This study investigates how brain activity and breathing changes in premature babies when their dose of caffeine treatment is changed or stopped. The study will assess premature babies receiving caffeine treatment as part of their clinical care. Brain activity will be recorded just before caffeine dose is changed and again two days afterwards. Breathing and other 'vital signs' (breathing rate, heart rate, oxygen saturation) will be recorded from the baby's monitor between the recordings of brain activity and for up to two weeks afterwards.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Caffeine | We will record infant\'s brain activity and vital signs when caffeine dose is changed or caffeine treatment is stopped. The decision to change dose/stop treatment will be made by the clinical team as part of routine care. No changes in caffeine treatment will be carried out solely for research purposes. |
Timeline
- Start date
- 2023-12-11
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2024-05-16
- Last updated
- 2024-05-16
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06416956. Inclusion in this directory is not an endorsement.